Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Zymeworks Inc.

NASDAQ: ZYME · Life Sciences · 7 alerts · CIK 1937653

Share price
$26.45Close, Nov 16
Market cap
$1.83B
Shares outstanding
69.03MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Zymeworks Inc. filings on SEC EDGAR ↗

4:40 PM ET 8-K/A
M&A Deal

Zymeworks M&A Deal with Theravance Biopharma, Inc.

Zymeworks Inc. filed an amendment to its previous 8-K to provide historical and pro forma financial statements following its completed acquisition of Theravance Biopharma, Inc. The merger involved a cash payment of $17.00 per share plus a contingent value right (CVR) tied to the future monetization and commercial success of ampreloxetine. The cash portion of the deal was financed through $350 million in non-recourse notes from OMERS Life Sciences and existing cash reserves.

Counterparty
Theravance Biopharma, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.